At its February 2026 meeting, EMA’s human medicines committee (CHMP) recommended 12 medicines for approval, covering vaccines, innovative treatments and biosimilars, and issued two negative opinions....
The European Commission has approved the amendment to the second contract with the pharmaceutical company Moderna for the activation, on behalf of all EU member states,...
Deliveries of Moderna’s COVID-19 vaccine are on track to meet the number of doses it promised to the European Union, a spokesperson for the US-based drugmaker...
The European Medicine’s Agency (EMA) human medicines committee (CHMP) has adopted several recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU....
The European Commission has approved a second contract with the pharmaceutical company Moderna, which provides for an additional purchase of 300 million doses (150 million in...
EMA has recommended granting a conditional marketing authorization for COVID-19 Vaccine Moderna to prevent coronavirus disease (COVID-19) in people from 18 years of age. This is...
The European Commission Chief Spokesperson Eric Mamer rebuffed criticism of the slow uptake of vaccines across the EU, since the authorization of the BioNTech vaccine at...
